Thyme Care
Financials
Estimates*
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 3.4m | 9.4m | 29.0m |
% growth | - | 176 % | 209 % |
Date | Investors | Amount | Round |
---|---|---|---|
$20.0m | Series A | ||
* | $60.0m | Series B | |
* | N/A | Late VC | |
* | $55.0m | Series C | |
* | $40.0m | Debt | |
Total Funding | CAD184m |
Related Content
Recent News about Thyme Care
EditThyme Care operates in the healthcare sector, specifically focusing on providing support and guidance to cancer patients. Their primary mission is to ensure that every cancer patient receives the highest quality care. They achieve this by integrating with existing clinical teams to offer round-the-clock guidance and support. Thyme Care's business model is centered around tech-enabled support, oncology expertise, and provider partnerships, all underpinned by analytics to measure and deliver high-quality care and outcomes.
Their services are targeted towards cancer patients, healthcare providers, and stakeholders in the healthcare industry. For patients, they offer personalized guidance and support throughout their cancer journey. For healthcare providers, Thyme Care operates as an extension of their clinical team, aligning incentives across healthcare stakeholders.
The company's unique selling proposition is its ability to reduce the total cost of care through targeted, cost-effective interventions. They claim to have a proven track record of reducing inpatient spend and cumulative inpatient visits per 1000 members, leading to significant savings for the navigated population.
Thyme Care generates revenue by offering its services to cancer patients and healthcare providers. The company's value proposition is its ability to provide high-quality care while reducing the overall cost of treatment, making it an attractive option for both patients and healthcare providers.
Keywords: Cancer Care, Tech-Enabled Support, Oncology Expertise, Provider Partnerships, Analytics, High-Quality Care, Cost-Effective Interventions, Reduced Inpatient Spend, Personalized Guidance, Healthcare Stakeholders.